메뉴 건너뛰기




Volumn 46, Issue 6, 2011, Pages 2586-2595

Anticancer effects of the metabolic products of the resveratrol analogue, DMU-212: Structural requirements for potency

Author keywords

Tubulin; Antiproliferation; Apoptosis; Cell cycle inhibition; DMU 212; Docking; HepG2 cells; MCF 7 cells; Molecular modeling; Paclitaxel binding site; Resveratrol

Indexed keywords

3 HYDROXY 4,5,4' TRIMETHOXYSTILBENE; 3' HYDROXY 3,4,5,4' TETRAMETHOXYSTILBENE; 3,4,5,4' TETRAMETHOXYSTILBENE; 4 HYDROXY 3,5,4' TRIMETHOXYSTILBENE; 4' HYDROXY 3,4,5 TRIMETHOXYSTILBENE; ANTINEOPLASTIC AGENT; BETA ACTIN; BETA TUBULIN; CYCLIN D1; DMU 212; DMU 214; DMU 281; DMU 291; DMU 807; MESSENGER RNA; PROTEIN BAX; PROTEIN BCL XL; PROTEIN P53; RESVERATROL; UNCLASSIFIED DRUG;

EID: 79955589531     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2011.03.049     Document Type: Article
Times cited : (62)

References (41)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.